Inventor · disambiguated record
Markus Kalla
Also filed as: KALLA MARKUS
10 granted patents·7 pending applications·22 citations·filing 1998–2022
83Inventor score
Files withBAVARIAN NORDIC AS11JANSSEN VACCINES & PREVENTION BV3JANSSEN SCIENCES IRELAND UNLIMITED CO2
Top patents by PatentIndex Score
17 records- 0193US11020476B2Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)JANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2018·Granted Jun 1, 2021·13 cites·20 claims
- 0286US11723970B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 0379US10881725B2Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccineBAVARIAN NORDIC AS·Filed 2017·Granted Jan 5, 2021·1 cites·27 claims
- 0478US11229693B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Jan 25, 2022·1 cites·20 claims
- 0571US11103570B2Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccineBAVARIAN NORDIC AS·Filed 2016·Granted Aug 31, 2021·1 cites·10 claims
- 0667US11654189B2Compositions and methods for enhancing the stability of transgenes in poxvirusesBAVARIAN NORDIC AS·Filed 2021·Granted May 23, 2023·0 cites·21 claims
- 0766US11571471B2Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccineBAVARIAN NORDIC AS·Filed 2021·Granted Feb 7, 2023·0 cites·20 claims
- 0864US2021393766A1Recombinant Modified Vaccinia Virus Ankara (MVA) Foot and Mouth Disease Virus (FMDV) VaccineBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 0961US2021268104A1Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV)JANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 1058US2024392257A1Utilization of Micro-RNA for Downregulation of Cytotoxic Transgene Expression by Modified Vaccinia Virus Ankara (MVA)BAVARIAN NORDIC AS·Filed 2022·Application pending·0 cites
- 1158US2025049903A1Therapy for Modulating Immune Response with Recombinant MVA Encoding IL-12BAVARIAN NORDIC AS·Filed 2022·Application pending·0 cites
- 1252US11052139B2Compositions and methods for enhancing the stability of transgenes in poxvirusesBAVARIAN NORDIC AS·Filed 2017·Granted Jul 6, 2021·0 cites·13 claims
- 1348US2023114464A1Conditions Improving Poxvirus StabilityBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 1446US2023190922A1Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating CancerBAVARIAN NORDIC AS·Filed 2020·Application pending·0 cites
- 1545US2023059344A1Medical Uses of 4-1BBL Adjuvanted Recombinant Modified Vaccinia Virus Ankara (MVA)BAVARIAN NORDIC AS·Filed 2020·Application pending·0 cites
- 1636US10517944B2Therapeutic HPV vaccine combinationsJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Dec 31, 2019·0 cites·20 claims
- 1723US6213103B1Fuel preheater for a piston internal combustion engine with heat vaporization of the fuelFiled 1998·Granted Apr 10, 2001·5 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Markus Kalla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →